Oncoinvent A

Oncoinvent A EPS

The Earnings per Share (EPS) of Oncoinvent A (ONCIN.OL) as of Nov 7, 2026 is -1.59 NOK. In the previous year, Earnings per Share (EPS) was -1.51 NOK — a change of 5.07% (lower).

EPS

-1.59NOK

YoY

5.07%

Last updated:

Earnings per Share (EPS) of Oncoinvent A is 2025 -1.59 NOK. Earnings per Share (EPS) of Oncoinvent A was 2024 -1.51 NOK. It decreases by 5.07% lower compared to the previous year.

The Oncoinvent A EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2021
-3.17 NOK
Jan 1, 2022
-3.09 NOK
Jan 1, 2023
-1.95 NOK
Jan 1, 2024
-1.51 NOK
Jan 1, 2025
-1.59 NOK
Jan 1, 2026 (e)
-37.12 NOK
Jan 1, 2027 (e)
-22.63 NOK
Jan 1, 2028 (e)
-6.18 NOK
The Oncoinvent A EPS history
YEAREPSYoY
est-6.18NOK-72.69%
est-22.63NOK-39.04%
est-37.12NOK+2,239.74%
-1.59NOK+5.07%
-1.51NOK-22.49%
-1.95NOK-36.98%
-3.09NOK-2.34%
-3.17NOK+704.12%
-0.39NOK-88.34%
-3.38NOK-5.66%
-3.58NOK-10.15%
-3.98NOK-4.57%
-4.17NOK+41.66%
-2.95NOK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Oncoinvent A Stock analysis

What does Oncoinvent A do? Oncoinvent ASA is a radiopharmaceutical company based in Oslo, Norway, operating within the Health Care sector. Listed on 13 December 2024, the firm employs 46 people and focuses on developing alpha-emitting radiotherapeutics for cancer patients. Its primary product, Radspherin, is an alpha-emitting radioactive microsphere therapy designed to treat metastatic cancers in body cavities. This suspension of calcium carbonate microspheres labelled with Radium-224 targets residual micro-metastases on intracavitary surfaces and in liquids after surgery, aiming to spare deeper organs from harmful radiation doses. Oncoinvent A is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncoinvent A stock

Earnings per Share (EPS) of Oncoinvent A is -1.59 NOK in 2025.

Earnings per Share (EPS) of Oncoinvent A changed from -1.51 NOK to -1.59 NOK, representing a 5.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Oncoinvent A since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Oncoinvent A

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Oncoinvent A